Nephros (NEPH) Stock
Specialized filtration developer for medical and water markets. Here's the price, business snapshot, and what's worth knowing about Nephros in October 2026.
Nephros Inc (NEPH) is a small-cap company operating in the medical technology and filtration space. It develops specialised filtration products used in clinical settings and water purification applications; these products are aimed at reducing contaminants and improving fluid quality for healthcare and industrial customers. With a market capitalisation of about $51.41 million, Nephros is a relatively small issuer and can be subject to greater share-price volatility and liquidity constraints than larger peers. Key points for investors to consider include the company’s product adoption in target markets, regulatory approvals, reimbursement dynamics, and the competitive landscape for medical and water filtration technologies. Financial transparency, cash runway and management execution are also central for smaller companies. This summary is for educational purposes only and is not personal financial advice; investors should do their own research, check the company’s filings and consider their risk tolerance before investing.
Nephros (NEPH) Stock Forecast
Analyst price target, next 12 months
$4.75
+29.4% vs today's $3.67
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Nephros have a consensus 12-month target of $4.75, above the current price of $3.67.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 3 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts highly recommend buying Nephros stock, believing it could rise significantly in value.
Financial Health
Nephros Inc. is showing solid revenue and cash flow, indicating a strong operational performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Niche filtration demand
Products target clinical and water-purification niches where quality matters; growth depends on adoption and reimbursement, though performance can vary.
Regulatory and market access
Regulatory approvals and contractual access to hospitals or municipalities are key growth drivers; setbacks or delays can affect prospects.
Small-cap dynamics
With a modest market cap, the stock can swing widely and may have limited liquidity, so consider risk tolerance and diversify accordingly.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
